Aytu Biopharma Inc (AYTU)
1.1700 x 1 1.2200 x 3
Post-market by (Cboe BZX)
1.1600 -0.0400 (-3.33%) 04/01/25 [NASDAQ]
1.1700 x 1 1.2200 x 3
Post-market 1.1604 +0.0004 (+0.03%) 16:04 ET
for Tue, Apr 1st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 06/30
| 08-2014 | 06-2014 | 08-2013 | 06-2013 | 08-2012 | |
| Sales | 1 | 59 | 2 | 2 | 2 |
| Gross Profit | 1 | 59 | 2 | 2 | 2 |
| Operating Expenses | 59 | 6,406 | 54 | 54 | 58 |
| Operating Income | -58 | -6,347 | -52 | -52 | -56 |
| Interest Expense | 4 | 46 | 5 | 5 | 3 |
| Pre-tax Income | -62 | -6,392 | -57 | -57 | -60 |
| Income Tax | N/A | -814 | N/A | 0 | N/A |
| Net Income Continuous | -62 | -5,579 | -57 | -57 | -60 |
| Net Income | $-62 | $-5,579 | $-57 | $-57 | $-60 |
| EPS Basic Total Ops | -0.01 | -0.80 | -0.01 | -0.12 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.80 | -0.01 | -0.14 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.80 | -0.01 | -0.12 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.80 | -0.01 | -0.14 | -0.01 |
| EBITDA(a) | $-53 | $-6,214 | $-48 | $-48 | $-50 |